Dr. Jeffrey Morgan Discusses the Reality of Bioprinted Hearts for Patients With Advanced Heart Failure

Dr. Jeffrey A. Morgan is Cardiac Surgeon Specializing in the Treatment of Advanced Heart Failure with Mechanical Assist Devices and Heart Transplantation; Dr. Morgan Strives to Contribute Innovative Solutions to the Medical Field and Works Diligently to Provide His Patients with a Superior Level of Care

HOUSTON, TX / ACCESSWIRE / June 25, 2019 / Cardiac surgeon and Chief Medical Officer for BIOLIFE4D – Dr. Jeffrey Morgan was recently featured on the Futuretech Podcast, where he provided a comprehensive overview of surgical therapies currently being utilized to treat heart failure.

The Futuretech podcast features exclusive innovations that are poised to transform our lives for the better. The podcast entails conversations which are led by industry experts to create an educational dialogue for up and coming technological trends effecting a wide range of industries. Futuretech focuses subject matter which includes artificial intelligence (AI), 3D printing, regenerative medicine, blockchain, and virtual reality.

In this episode, Dr. Morgan discusses the causes of heart failure and examines the positive and negative aspects of various surgical therapies currently available including total artificial heart (TAH) and left ventricular assist devices (LVADS).

He also details the future direction of bioprinted hearts and explains how 3D bioprinting has the potential to transform the medical field. The plan is for bioprinting to create functional biological structures with the potential to restore, improve, or replace existing organ function.

Dr. Jeffrey Morgan explains how these transformative medical benefits could potentially ultimately eliminate the rejection of transplanted organs by utilizing a patient’s cells to create the organ. Additionally, the use of bioprinting would decrease the wait time for donated organs and minimize the need to obtain organs from donors.

To listen to this podcast please visit https://www.futuretechpodcast.com/podcasts/growing-beating-hearts-from-cells-dr-jeffrey-a-morgan-chief-medical-officer-for-biolife4d/

About Dr. Jeffrey Morgan

Dr. Morgan is a cardiac surgeon who specializes in adult cardiac surgery and performs coronary artery bypass grafting, mitral valve repair/replacement, aortic valve replacement, implantation of LVADs, artificial hearts, and heart transplantation. He trained at New York University for cardiac surgery followed by advanced training at Columbia Presbyterian Medical Center for advanced heart failure – LVADs and heart transplants.

Contact:

Dr. Jeffrey Morgan
info@drjeffreymorgan.live

SOURCE: Dr. Jeffrey Morgan

View source version on accesswire.com:
https://www.accesswire.com/549801/Dr-Jeffrey-Morgan-Discusses-the-Reality-of-Bioprinted-Hearts-for-Patients-With-Advanced-Heart-Failure

user

Recent Posts

Fangzhou Showcases AI Governance Breakthroughs at Guangzhou Closed-Door Summit on Vertical-Specific AI Models

GUANGZHOU, China, April 9, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leading…

3 hours ago

NervGen Provides Quarterly “At-The-Market” Equity Program Update

Vancouver, British Columbia--(Newsfile Corp. - April 9, 2025) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB:…

9 hours ago

Acurion Unveils Rebrand, New Leadership Team, and Series A Fundraising Launch

LA JOLLA, Calif., April 9, 2025 /PRNewswire/ -- Acurion, formerly known as io9, today announced…

9 hours ago

SportsMed Physical Therapy Expands with Acquisition of Mendham Physical Therapy in Morris County, NJ

New location marks the company's 45th clinic across New Jersey and Connecticut MENDHAM, N.J., April…

9 hours ago

Agilisium launches domain-trained Insights Generation AI Agent to boost Life Sciences intelligence

LOS ANGELES, April 9, 2025 /PRNewswire/ -- Agilisium – a leading Data Innovation & Agentic…

9 hours ago

MEDVA’s Secure Facility Enables Offshore Staff to Access EMRs like Epic While Maintaining Healthcare Compliance Standards

HENDERSON, Nev., April 9, 2025 /PRNewswire/ -- As healthcare data breaches surge to record levels, MEDVA,…

9 hours ago